Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia

Objectives: To evaluate the efficacy of intravitreal bevacizumab treatment in type 2 idiopathic macular telangiectasia (IMT). Materials and Methods: Six eyes of 5 patients with type 2 IMT who received intravitreal bevacizumab between 2009 and 2014 were included in this study. All the patients had a...

Full description

Bibliographic Details
Published in:	Türk Oftalmoloji Dergisi
Main Authors:	Tuğba Aydoğan, Gürkan Erdoğan, Cihan Ünlü, Ahmet Ergin
Format:	Article
Language:	English
Published:	Turkish Ophthalmology Society 2016-12-01
Subjects:	Type 2 idiopathic macular telangiectasia intravitreal bevacizumab macular edema
Online Access:	http://www.oftalmoloji.org/article_12561/Intravitreal-Bevacizumab-Treatment-In-Type-2-Idiopathic-Macular-Telangiectasia

Similar Items

Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
by: Fariba Ghassemi, et al.
Published: (2017-01-01)

Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
by: Rajvardhan Azad, et al.
Published: (2012-01-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial
by: Alireza Ramezani, et al.
Published: (2024-03-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01)

Comparison of intravitreal bevacizumab with macular photocoagulation for treatment of diabetic macular edema:a systemic review and Meta-analysis
by: Xiang-Dong Liu, et al.
Published: (2014-12-01)

A complete clinical review of idiopathic macular telangiectasia
by: P Jayasri, et al.
Published: (2023-01-01)

Effects of Oral Vitamin D Supplement Therapy on Clinical Outcomes of Intravitreal Bevacizumab in Diabetic Macular Edema
by: Saeed Karimi, et al.
Published: (2021-01-01)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
by: Kumar Atul, et al.
Published: (2007-01-01)

Efficacy and safety analysis of intravitreal bio-similar products of bevacizumab in patients with macular edema because of retinal diseases
by: Ruchi Agarwal, et al.
Published: (2023-01-01)

COMPARISON OF INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE WITH INTRAVITREAL BEVACIZUMAB ALONE IN MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
by: Usman Attique, et al.
Published: (2021-03-01)

Visual outcome after intravitreal bevacizumab (avastin) in the treatment of diabetic macular oedema
by: Saquib Naeem, et al.
Published: (2014-12-01)

ROLE OF INTRAVITREAL BEVACIZUMAB INJECTION FOR MANAGEMENT OF NEOVASCULAR AGE RELATED MACULAR DEGENERATION
by: Neha K. Desai, et al.
Published: (2016-06-01)

Off-label use of intravitreal bevacizumab: A global conundrum
by: Samya Singh, et al.
Published: (2024-04-01)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
by: Elad Moisseiev, et al.
Published: (2010-08-01)

Clinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema
by: Karen Joyce G, Castro, MD, et al.
Published: (2014-12-01)

Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema:a meta-analysis
by: Xiao-Ling Zhang, et al.
Published: (2013-08-01)

Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure
by: Sukhum Silpa-archa, et al.
Published: (2025-06-01)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
by: Srikant Padhy, et al.
Published: (2018-01-01)

Combined Treatment with Bevacizumab and Triamcinolone Acetonide for Macular Edema Due to Retinal Vein Occlusion
by: Maja Vinković, et al.
Published: (2020-01-01)

Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia
by: Berger TA, et al.
Published: (2021-03-01)

Evaluation of intravitreal corticosteroids as an adjuvant to bevacizumab for diabetic macular edema using electroretinogram
by: Hesham A Enany
Published: (2015-01-01)

Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
by: Lokman Balyen, et al.
Published: (2018-01-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Factors associated with 1-year visual response following intravitreal bevacizumab treatment for diabetic macular edema: a retrospective single center study
by: Janejit Choovuthayakorn, et al.
Published: (2021-03-01)

Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion
by: Mei-Zi Wang, et al.
Published: (2016-01-01)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
by: Gopal K Das, et al.
Published: (2018-01-01)

Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia
by: Ökkeş Baz, et al.
Published: (2017-06-01)

Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report
by: Anisha Seth, et al.
Published: (2016-04-01)

Intravitreal Stivant® (a biosimilar to bevacizumab) alone versus combined with triamcinolone in center-involved diabetic macular edema
by: Arash Daneshtalab, et al.
Published: (2025-09-01)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
by: Murat Garlı, et al.
Published: (2021-12-01)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
by: Shrestha R, et al.
Published: (2019-10-01)

Intravitreal Bevacizumab Alone Vs Combined With Topical Timolol-Dorzolamide or Dorzolamide for Diabetic Macular Edema: A Systematic Review and Meta-Analysis
by: Hubayni RA, et al.
Published: (2025-03-01)

Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical study
by: Francyne Veiga Reis, et al.
Published: (2023-03-01)

Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study
by: Seemant Raizada, et al.
Published: (2015-01-01)

Macular Hole Formation in Eye After Cryotherapy and Intravitreal Bevacizumab Treatment for Vasoproliferative Tumor
by: Sato A, et al.
Published: (2020-09-01)

Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01)

Triple Therapy Management of Macular Telangiectasia
by: Hammad Rashid Nasti, et al.
Published: (2015-04-01)

Autologous neurosensory retinal flap for closure of refractory macular hole in a patient with macular telangiectasia
by: Andrew Hewson, et al.
Published: (2020-06-01)